Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.55 USD | +1.09% | -4.43% | 0.00% |
Jun. 05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
Jun. 05 | Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARRIVENT BIOPHARMA, INC. | Other Biotechnology & Medical Research | +1.09% | -4.43% | - | - | - | 621M |
- Stock Market
- Equities
- AVBP Stock
- Charts ArriVent BioPharma, Inc.
- Relative Strength Chart